Also trades as: PMN.TO (TSX) · $vol 0M
PMN NASDAQ
ProMIS Neurosciences, Inc.
1W: -16.6%
1M: -32.8%
3M: -31.4%
YTD: +31.6%
1Y: -17.5%
3Y: -80.7%
5Y: -95.5%
$9.40
+0.02 (+0.21%)
Weekly Expected Move ±13.0%
$7
$8
$9
$11
$12
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$40.2B
-238600.7% ▼
Net Income
-$39.7B
-1429425.7% ▼
EPS (Diluted)
$-22.61
-922.2% ▼
EBITDA
-$55M
-2030.0% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $8K | $0 | $0 | $0 | $0 |
| YoY Growth | +420.0% | -100.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $6M | $0 | $10M | $0 | $0 |
| Gross Profit | -$6M | $0 | -$10M | $0 | $0 |
| Gross Margin | -71796.9% | — | — | — | — |
| R&D Expenses | $5M | $16M | $8M | $11M | $33.4B |
| SG&A Expenses | $3M | $7M | $6M | $6M | $6.8B |
| Operating Expenses | $8M | $23M | $8M | $17M | $55M |
| Operating Income | -$8M | -$23M | -$19M | -$17M | -$40.2B |
| Operating Margin | -101363.6% | — | — | — | — |
| Interest Expense | $416K | $282K | $201K | $77K | $0 |
| Income Before Tax | -$9M | -$18M | -$18M | $3M | -$39.7B |
| Tax Expense | $415K | $0 | $0 | $0 | $0 |
| Net Income | -$10M | -$18M | -$18M | $3M | -$39.7B |
| Net Margin | -118662.2% | — | — | — | — |
| EPS (Diluted) | $-41.75 | $-42.50 | $-35.50 | $2.75 | $-22.61 |
| EBITDA | -$9M | -$18M | -$18M | $3M | -$55M |
| Shares Outstanding | 231425 | 300104 | 491708 | 1M | 1.76B |